上海医学影像
上海醫學影像
상해의학영상
SHANGHAI MEDICAL IMAGING
2009年
2期
113-116
,共4页
吴春芳%朱勇%乌有弘%蔡瑾%罗行中
吳春芳%硃勇%烏有弘%蔡瑾%囉行中
오춘방%주용%오유홍%채근%라행중
卵巢%囊腺癌%磁共振成像%体层摄影术,X线计算机
卵巢%囊腺癌%磁共振成像%體層攝影術,X線計算機
란소%낭선암%자공진성상%체층섭영술,X선계산궤
Ovary%Cystadenocarcinoma%Magnetic resonance imaging%Tomography,Xray-computed
目的 探讨MRI和CT对卵巢浆液性囊腺癌和黏液性囊腺癌的应用价值与选择.方法 回顾性分析22例MRI诊断卵巢囊腺癌经手术和病理证实的资料,结合CT对照分析.结果 MKI诊断14/22例为浆液性囊腺癌,8/22例为黏液性囊腺癌.病理13/14例为浆液性囊腺癌,1/14例为浆、黏液性囊腺瘤;5/8例为黏液性囊腺癌,3/8例为黏液性囊腺瘤.CT诊断10/20例为浆液性囊腺癌,10/20例为黏液性囊腺癌.病理9/10例为浆液性囊腺癌,1/10例为卵巢透明细胞癌;9/10例为黏液性囊腺癌,1/10例为浆液性囊腺癌伴出血.MRI及CT均可显示卵巢囊腺癌为囊实性病变,即敏感性差异不大,在特异性方面前者在平扫时显示更为优越,但在增强后的特异性则后者又超过前者,原因是MRI在增强扫描时采用T1WI,此时黏液改变亦为高信号与显示的对比剂相混杂导致增强失真的效果,而CT增强扫描则可明确显示局部的不规则囊壁以及壁结节的形成.因此CT所显示的特异性更强,亦即对诊断的正确性更高.结论 浆液性囊腺癌MRI与CT应用价值相近,黏液性囊腺癌CT定性优于MRI.
目的 探討MRI和CT對卵巢漿液性囊腺癌和黏液性囊腺癌的應用價值與選擇.方法 迴顧性分析22例MRI診斷卵巢囊腺癌經手術和病理證實的資料,結閤CT對照分析.結果 MKI診斷14/22例為漿液性囊腺癌,8/22例為黏液性囊腺癌.病理13/14例為漿液性囊腺癌,1/14例為漿、黏液性囊腺瘤;5/8例為黏液性囊腺癌,3/8例為黏液性囊腺瘤.CT診斷10/20例為漿液性囊腺癌,10/20例為黏液性囊腺癌.病理9/10例為漿液性囊腺癌,1/10例為卵巢透明細胞癌;9/10例為黏液性囊腺癌,1/10例為漿液性囊腺癌伴齣血.MRI及CT均可顯示卵巢囊腺癌為囊實性病變,即敏感性差異不大,在特異性方麵前者在平掃時顯示更為優越,但在增彊後的特異性則後者又超過前者,原因是MRI在增彊掃描時採用T1WI,此時黏液改變亦為高信號與顯示的對比劑相混雜導緻增彊失真的效果,而CT增彊掃描則可明確顯示跼部的不規則囊壁以及壁結節的形成.因此CT所顯示的特異性更彊,亦即對診斷的正確性更高.結論 漿液性囊腺癌MRI與CT應用價值相近,黏液性囊腺癌CT定性優于MRI.
목적 탐토MRI화CT대란소장액성낭선암화점액성낭선암적응용개치여선택.방법 회고성분석22례MRI진단란소낭선암경수술화병리증실적자료,결합CT대조분석.결과 MKI진단14/22례위장액성낭선암,8/22례위점액성낭선암.병리13/14례위장액성낭선암,1/14례위장、점액성낭선류;5/8례위점액성낭선암,3/8례위점액성낭선류.CT진단10/20례위장액성낭선암,10/20례위점액성낭선암.병리9/10례위장액성낭선암,1/10례위란소투명세포암;9/10례위점액성낭선암,1/10례위장액성낭선암반출혈.MRI급CT균가현시란소낭선암위낭실성병변,즉민감성차이불대,재특이성방면전자재평소시현시경위우월,단재증강후적특이성칙후자우초과전자,원인시MRI재증강소묘시채용T1WI,차시점액개변역위고신호여현시적대비제상혼잡도치증강실진적효과,이CT증강소묘칙가명학현시국부적불규칙낭벽이급벽결절적형성.인차CT소현시적특이성경강,역즉대진단적정학성경고.결론 장액성낭선암MRI여CT응용개치상근,점액성낭선암CT정성우우MRI.
Objective To discuss the value of clinical application and choice with MRI/CT for diagnosing ovarian serous cystadenocarcinoma and ovarian mucinous cystadenocarcinoma. Methods To analyse 22 cases of ovarian through MRI confirmed by surgicopathology and compare with those of the relevant CT cystadenocarcinoma retrospectively. Results MRI revealed 14/22 cases of ovarian serous cystadenocarcinoma,8/22 cases of ovarian mucinous cystadenocarcinoma, and pathology confirmed 13/14 cases as the serous cystadenocarcmoma,1/14 case as the ovarian seromucinous cystadenoma,5/8 cases for mucinous cystadenocarcinoma. 3/8 cases for mucinous cystadenoma. CT showed 10/20 cases as the serous cystadenocarcinoma, 10/20 cases as the mucmous cystadenocarcinoma, and pathology proved 9/10 cases for serous cystadenocarcinoma, 1/10 case for ovarian clear cell carcinoma, 9/10 cases for mucinons cystadenocarcinoma, 1/10 case for serous cystadenocarcinoma complicated with bleeding. Furthermore, the characteristic or unique features contributed with MRI and CT were comprehended as follows. Both of MRI and CT can demonstrate ovarian cystadenocarcinoma as cystic and consistent mass that means no significant difference in sensitivities. As regards to specificities, plain MRI can unveil more clearly the mass ingredients than those through CT, outcoming with profitable benefit in specificity; but conversely enhanced CT can demonstrate the enhanced regional wall irregularities and nodules while MRI can' t do so clearly and precisely due to the presence of higher signal intensities caused by mucin on enhanced MRI. T1WI with intermingling of the paramagnetic substance (GD. DTPA), leading to comparatively lower specificity. Conclusion MRI and CT are nearly equal in application of diagnosing ovarian serous cystadenocarcmoma. But CT is superior to MRI in diagnosing the qualification of ovarian mucinous cystadenocarcinoma.